tradingkey.logo

IQVIA Holdings Inc

IQV
230.750USD
-4.870-2.07%
取引時間 ET15分遅れの株価
39.30B時価総額
31.46直近12ヶ月PER

IQVIA Holdings Inc

230.750
-4.870-2.07%

詳細情報 IQVIA Holdings Inc 企業名

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Incの企業情報

企業コードIQV
会社名IQVIA Holdings Inc
上場日May 09, 2013
最高経営責任者「CEO」Bousbib (Ari)
従業員数88000
証券種類Ordinary Share
決算期末May 09
本社所在地2400 Ellis Road
都市DURHAM
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号27703
電話番号19199982000
ウェブサイトhttps://ir.iqvia.com/
企業コードIQV
上場日May 09, 2013
最高経営責任者「CEO」Bousbib (Ari)

IQVIA Holdings Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-907.00%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-117138.00%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+1592.00%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+1592.00%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+1047.00%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+1676.00%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
+1047.00%
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-84.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-907.00%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-117138.00%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+1592.00%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+1592.00%

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Americas
1.93B
47.15%
Europe & Africa Region
1.30B
31.63%
Asia Pacific Region
870.00M
21.22%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sat, Jan 10
更新時刻: Sat, Jan 10
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.69%
BlackRock Institutional Trust Company, N.A.
5.54%
State Street Investment Management (US)
4.43%
GIC Private Limited
3.84%
他の
68.10%
株主統計
株主統計
比率
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.69%
BlackRock Institutional Trust Company, N.A.
5.54%
State Street Investment Management (US)
4.43%
GIC Private Limited
3.84%
他の
68.10%
種類
株主統計
比率
Investment Advisor
47.26%
Investment Advisor/Hedge Fund
36.03%
Sovereign Wealth Fund
4.94%
Pension Fund
4.16%
Hedge Fund
3.22%
Research Firm
2.37%
Bank and Trust
1.95%
Individual Investor
0.92%
Family Office
0.15%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
2052
169.60M
99.59%
-17.97M
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
19.41M
11.4%
-186.59K
-0.95%
Sep 30, 2025
Harris Associates L.P.
11.39M
6.69%
-365.92K
-3.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.44M
5.54%
+67.42K
+0.72%
Sep 30, 2025
State Street Investment Management (US)
7.55M
4.43%
-75.92K
-1.00%
Sep 30, 2025
GIC Private Limited
6.54M
3.84%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.35M
2.55%
+132.36K
+3.14%
Sep 30, 2025
CPP Investments
4.12M
2.42%
-52.91K
-1.27%
Sep 30, 2025
AllianceBernstein L.P.
3.60M
2.11%
+41.64K
+1.17%
Sep 30, 2025
Boston Partners
3.56M
2.09%
+1.58M
+80.09%
Sep 30, 2025
Artisan Partners Limited Partnership
3.43M
2.02%
+161.09K
+4.92%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
First Trust Nasdaq Lux Digi Health Solutions ETF
9.1%
Langar Global HealthTech ETF
7.83%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.98%
iShares Biotechnology ETF
3.23%
iShares Health Innovation Active ETF
3.05%
Adaptive Core ETF
3.04%
Invesco Bloomberg Pricing Power ETF
2.24%
Running Oak Efficient Growth ETF
2.16%
Invesco Zacks Mid-Cap ETF
2.08%
詳細を見る
First Trust Nasdaq Lux Digi Health Solutions ETF
比率9.1%
Langar Global HealthTech ETF
比率7.83%
Global X HealthTech ETF
比率5.5%
VanEck Biotech ETF
比率4.98%
iShares Biotechnology ETF
比率3.23%
iShares Health Innovation Active ETF
比率3.05%
Adaptive Core ETF
比率3.04%
Invesco Bloomberg Pricing Power ETF
比率2.24%
Running Oak Efficient Growth ETF
比率2.16%
Invesco Zacks Mid-Cap ETF
比率2.08%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI